MSH helps to strengthen the supply chain for malaria commodities at all levels, from global markets to private medicine vendors, to community health workers. We help global agencies, national governments, and local stakeholders make the best use of resources and adopt policies to preserve the efficacy of effective anti-malarial drugs. MSH also improves the capacity of ministries of health to deliver appropriate treatments by providing technical assistance in policy design, supply chain management, drug efficacy, drug safety, and quality control. Our work has helped to improve the availability and use of anti-malarial medicines and diagnostics in over 30 countries.
Policy Design and Implementation
MSH works with all levels of the health system to design and implement effective malaria treatment and prevention policies. At the national level, we facilitate partner coordination to build consensus on prevention and treatment strategies for malaria and infectious disease, including the development of standard treatment guidelines, lists of essential medicines, and standard operating procedures. In partnership with regulatory bodies, we also work to strengthen anti-malarial product controls for improved safety and efficacy. In facilities and communities, MSH facilitates the transition and roll-out of national-level guidelines for artemisinin-based combination therapies, rapid diagnostic tests, and recently, injectable artesunate for the treatment of severe malaria.
Supply Chain Management
In partnership with key stakeholders at the national, regional, and facility levels, MSH develops effective pharmaceutical forecasting and requisitioning systems and improved drug storage techniques. Our field teams help ministries procure essential medicines and commodities and improve management information systems to facilitate accurate data on product availability, consumption, and pricing. MSH’s tools and training courses equip health workers to assess pharmaceutical management systems for malaria commodities, and these assessments are then used to inform evidence-based interventions.
Improving Drug Efficacy
MSH trains and equips laboratory technicians to verify malaria cases through microscopy or rapid diagnostic testing. This training helps to reduce presumptive diagnosis and treatment of malaria, thereby improving malaria drug efficacy. Our training and supervision initiatives further help to reduce drug resistance by building the capacity of health workers to follow treatment guidelines and national recommendations.
Quality Control and Drug Safety
MSH provides technical assistance to ensure the quality of anti-malarial drugs and tests by implementing interventions focused on:
- Detecting and removing substandard and counterfeit products from the market,
- Facilitating batch testing of rapid diagnostic tests according to the World Health Organization’s recommendations, and
- Improving the quality of laboratory diagnosis.
MSH partners with national drug regulatory agencies to ensure drug safety by monitoring adverse drug events. In addition, we partner with Roll Back Malaria; the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the Gates Foundation; UNITAID; and other organizations to ensure a safe, effective, and consistent malaria pharmaceutical and diagnostic commodities supply chain.